Big Gain For TransCode Therapeutics Inc.
Tue, Jan 28, 2025 at 07:25 PM
TransCode Therapeutics Inc. (RNAZ:NASDAQ) rocketted at $9.94, representing a gain of 45.5%. On Tue, Jan 28, 2025, RNAZ:NASDAQ touched a New 2-Week High of $9.94. The stock appeared on our News Catalysts scanner on Tue, Jan 14, 2025 at 09:25 AM in the 'BIOTECH' category. From Tue, Jan 14, 2025, the stock recorded 55.56% Up Days and 70.00% Green Days
The stock spiked on Tue, Jan 28, 2025 at $16.73 with a volume of 37M+.
About TransCode Therapeutics Inc. (RNAZ:NASDAQ)
TransCode Therapeutics Inc is an RNA oncology company. It is created to defeat the cancer through the intelligent design and effective delivery of RNA therapeutics.
Top 10 Gainers:
- F45 Training Holdings Inc. (FXLV:NYSE), 269.23%
- Dunxin Financial Holdings Limited (DXF:NYSEMKT), 168.26%
- Biomotion Sciences (SLXN:NASDAQ), 132.76%
- Trinity Biotech plc (TRIB:NASDAQ), 78.95%
- Planet Image International Limited (YIBO:NASDAQ), 66.88%
- Diginex Limited (DGNX:NASDAQ), 59.13%
- IMAC Holdings Inc. (BACK:NASDAQ), 47.17%
- TransCode Therapeutics Inc. (RNAZ:NASDAQ), 45.53%
- LatAmGrowth SPAC (LATG:NASDAQ), 40%
- Hepion Pharmaceuticals, Inc. (HEPA:NASDAQ), 34.97%